Cargando…

Major adverse cardiovascular event definitions used in observational analysis of administrative databases: a systematic review

BACKGROUND: Major adverse cardiovascular events (MACE) are increasingly used as composite outcomes in randomized controlled trials (RCTs) and observational studies. However, it is unclear how observational studies most commonly define MACE in the literature when using administrative data. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosco, Elliott, Hsueh, Leon, McConeghy, Kevin W., Gravenstein, Stefan, Saade, Elie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571870/ https://www.ncbi.nlm.nih.gov/pubmed/34742250 http://dx.doi.org/10.1186/s12874-021-01440-5

Ejemplares similares

2730. Estimating Deaths Attributable to Influenza Mortality Using Traditional and Novel Forecasting Methods
por: McConeghy, Kevin, et al.
Publicado: (2019)

Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

901. The Impact of Cost-Free On-Site Influenza Point of Care Antigen Testing on Influenza Detection in Nursing Homes
por: Abdul, Yasin, et al.
Publicado: (2023)

LONG-TERM CARE FACILITY VARIATION IN THE INCIDENCE OF PNEUMONIA AND INFLUENZA HOSPITALIZATIONS
por: Bosco, Elliott, et al.
Publicado: (2019)

Risk factors for pneumonia and influenza hospitalizations in long-term care facility residents: a retrospective cohort study
por: Moyo, Patience, et al.
Publicado: (2020)

Long-term Care Facility Variation in the Incidence of Pneumonia and Influenza
por: Bosco, Elliott, et al.
Publicado: (2019)

Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

LB-19. Association between contract staffing and reported outbreaks of SARS-CoV-2 in a cluster-randomized trial of 965 U.S. nursing homes
por: McConeghy, Kevin, et al.
Publicado: (2020)

The burden of respiratory infections among older adults in long-term care: a systematic review
por: Childs, Arielle, et al.
Publicado: (2019)

Estimated Cardiorespiratory Hospitalizations Attributable to Influenza and Respiratory Syncytial Virus Among Long-term Care Facility Residents
por: Bosco, Elliott, et al.
Publicado: (2021)

Geographic Variation in Pneumonia and Influenza in Long-Term Care Facilities: A National Study
por: Bosco, Elliott, et al.
Publicado: (2020)

996. A Cluster-Randomized Trial of Adjuvanted Trivalent Influenza Vaccine vs. Standard Dose in US Nursing Homes
por: Gravenstein, Stefan, et al.
Publicado: (2018)

Temperature in Nursing Home Residents Systematically Tested for SARS-CoV-2
por: Rudolph, James L., et al.
Publicado: (2020)

Validation of novel identification algorithms for major adverse cardiovascular events in a Japanese claims database
por: Shima, Daisuke, et al.
Publicado: (2020)

Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
por: Zhao, Hui, et al.
Publicado: (2023)

Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies
por: Armstrong, Ehrin J., et al.
Publicado: (2013)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database
por: Nagai, Junko, et al.
Publicado: (2021)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study
por: Filion, Kristian B, et al.
Publicado: (2020)

Spontaneous Reporting on Adverse Events by Consumers in the United States: An Analysis of the Food and Drug Administration Adverse Event Reporting System Database
por: Toki, Tadashi, et al.
Publicado: (2018)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
por: Gu, Sophie Z, et al.
Publicado: (2023)

Evaluating adverse events in databases
por: Lovell, Katie, et al.
Publicado: (2023)

The Association of a Frailty Index and Incident Delirium in Older Hospitalized Patients: An Observational Cohort Study
por: Sillner, Andrea Yevchak, et al.
Publicado: (2020)

Cardiovascular Toxicities of Ibrutinib: A Pharmacovigilance Study Based on the United States Food and Drug Administration Adverse Event Reporting System Database
por: Zheng, Yi, et al.
Publicado: (2023)

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
por: Armstrong, Ehrin J., et al.
Publicado: (2014)

Occurrence and Impact of Gastrointestinal Bleeding and Major Adverse Cardiovascular Events during Sepsis: A 15-Year Observational Study
por: Hsieh, Ming-Shun, et al.
Publicado: (2020)

Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database
por: Shimada, Kazuyo, et al.
Publicado: (2019)

Endothelial Dysfunction Is Associated With Major Adverse Cardiovascular Events in Peritoneal Dialysis Patients
por: Lee, Mi Jung, et al.
Publicado: (2014)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population
por: Mendonça, Maria Isabel, et al.
Publicado: (2021)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
por: Jiang, Joy, et al.
Publicado: (2023)

Necroptosis Drives Major Adverse Cardiovascular Events During Severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

Major adverse cardiovascular events are associated with necroptosis during severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s4crrdkmnle9ei9sed807e8ssa